CorMedix (CRMD) Non-Current Assets (2016 - 2025)
CorMedix has reported Non-Current Assets over the past 15 years, most recently at $459.1 million for Q4 2025.
- Quarterly results put Non-Current Assets at $459.1 million for Q4 2025, up 10649.03% from a year ago — trailing twelve months through Dec 2025 was $959.7 million (up 5275.36% YoY), and the annual figure for FY2025 was $459.1 million, up 10649.03%.
- Non-Current Assets reached $459.1 million in Q4 2025 per CRMD's latest filing, down from $491.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $491.3 million in Q3 2025 and bottomed at $1.2 million in Q2 2021.
- Median Non-Current Assets over the past 5 years was $2.5 million (2021), compared with a mean of $50.2 million.
- The largest annual shift saw Non-Current Assets dropped 1.9% in 2023 before it skyrocketed 10986.07% in 2025.
- Over 5 years, Non-Current Assets stood at $2.5 million in 2021, then grew by 0.42% to $2.5 million in 2022, then increased by 4.92% to $2.6 million in 2023, then surged by 63.67% to $4.3 million in 2024, then surged by 10649.03% to $459.1 million in 2025.
- Business Quant data shows Non-Current Assets for CRMD at $459.1 million in Q4 2025, $491.3 million in Q3 2025, and $4.5 million in Q2 2025.